netFormulary Leeds Formulary NHS
Leeds Teaching Hospitals NHS TrustLeeds North CCG
Leeds and York Partnership NHS Foundation TrustLeeds South and East CCG
Leeds Community Healthcare NHS TrustLeeds West CCG

Welcome to the Leeds Medicines Formulary

Useful Links

Compliance with NICE technology appraisals
Antimicrobial guidelines

plus: Yellow Card e-learning

Further Medicines Management Resources

NHS Leeds Traffic Light List

News Feed

MHRA: Drug Safety Update (Mar 18): daclizumab, Esmya (ulipristal acetate), head lice treatments

MHRA: Drug Safety Update (Feb 18): Mysodelle, mycophenolate, contrast agents
MHRA: Drug Safety Update: daclizumab, epo, co-dydramol (Jan 18)
MHRA: Drug Safety Update (Dec 17): fingolimod, eluxadoline, cladribine + more
LTHT: Common alternatives in swallowing difficulties and feeding tubes
MHRA: Drug Safety Update (Nov 17): quinine, gentamicin, tacrolimus
>>> more news

The Leeds Formulary aims to provide information on medicines supporting safe, evidence-based, cost-effective practice. Whilst the formulary contains links to relevant policies and guidelines, the prescriber retains the responsibility for the appropriate use of this information. For further information on the development of the Leeds Formulary and participating organisations, please go to our 'About' page. Comments about any aspect of the formulary can be made by using the feedback tab at the top of this page. Updates to the formulary are shared via the newsfeed above and on the Leeds Medicines Management Hub on Leeds Health Pathways. You can also follow us on Twitter - @LeedsFormulary.

LTHT Injectable Medicines Guides (Medusa)

Adult IV monographs

Paediatric IV monographs

Adult BNF

Paediatric BNF

BNF Apps (iOS and Android)

   Last updated: 22/04/2018 15:00:28